To identify any genetic defect of patients in the current study, such as having underlying CHD and associated defects, we performed a molecular analysis of the key genes NKX2.5 and ACTC1, which play a critical role in both structural and functional development of cardiomyocytes. This evidence concerns the gene ACTC1 and coronary artery disorder.